Synthetic and systems biology principles in the design of programmable oncolytic virus immunotherapies for glioblastoma.

Monie, Dileep D; Bhandarkar, Archis R; Parney, Ian F; Correia, Cristina; Sarkaria, Jann N; Vile, Richard G; Li, Hu

Monie, Dileep D; Bhandarkar, Archis R; Parney, Ian F; Correia, Cristina; Sarkaria, Jann N; Vile, Richard G; Li, Hu.

Afiliação

Monie DD; Departments of1Immunology.
Bhandarkar AR; 6Mayo Clinic Alix School of Medicine.
Parney IF; 7Mayo Clinic Graduate School of Biomedical Sciences; and Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Correia C; 6Mayo Clinic Alix School of Medicine.
Sarkaria JN; Departments of1Immunology.
Vile RG; 3Neurosurgery.
Li H; 5Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic.

Neurosurg Focus ; 50(2): E10, 2021 02.

Article em En | MEDLINE | ID: mdl-33524942

Assuntos

Glioblastoma; Terapia Viral Oncolítica; Vírus Oncolíticos; Glioblastoma/genética; Glioblastoma/terapia; Humanos; Imunoterapia; Vírus Oncolíticos/genética; Biologia de Sistemas; Microambiente Tumoral

Palavras-chave

cancer immunotherapy; glioblastoma; oncolytic virus; synthetic biology; systems biology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glioblastoma / Vírus Oncolíticos / Terapia Viral Oncolítica Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google